Substance / Medication

Atropine sulfate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

12 trials linked to this intervention

12
Total Trials
3
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Vonoprazan vs. Lansoprazole for the treatment of endoscopic submucosal dissection induced gastric ulcer: a systematic review and meta-analysis.
Miao Tiaotiao, Zhang Yao, Bai Lin et al. · Rev Esp Enferm Dig · 2023
PMID: 35899702Meta-Analysis
Pediatric poisoning deaths in Saudi Arabia: A systematic review.
Almutairi Saad A, Alsaleem Jassim Hijji, Alrashed Mahdi A et al. · Leg Med (Tokyo) · 2023
PMID: 36395600Meta-Analysis
Meta-analysis of the association between new hypoglycemic agents and digestive diseases.
Wang Yu-Wen, Lin Jin-Hao, Yang Cui-Shan · Medicine (Baltimore) · 2022
PMID: 36042668Meta-AnalysisFull text (PMC)
Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy.
Dias Bruno L Scofano, Fernandes Alexandre R, Maia Heber de S · Arq Neuropsiquiatr · 2017
PMID: 28591387RCT
Objective evaluation of the systemic effects of topical application of 1% atropine sulfate ophthalmic solution in healthy horses.
Wehrman Rita F, Gemensky-Metzler Anne J, Zibura Ashley E et al. · J Am Vet Med Assoc · 2017
PMID: 29154707RCT
Clinical and bioavailability studies of sublingually administered atropine sulfate.
Rajpal Sheetal, Ali Raisuddin, Bhatnagar Aseem et al. · Am J Emerg Med · 2010
PMID: 20159382Trial
Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote.
Ali Raisuddin, Jain Gaurav K, Iqbal Zeenat et al. · Nanomedicine · 2009
PMID: 18799362Trial
Topical atropine sulfate for the treatment of axillary hyperhidrosis.
Grimalt Ramon, Domínguez Tordera Patricia, Callejas Marco A · J Cosmet Dermatol · 2006
PMID: 17716247Trial
Oral atropine sulfate for infantile hypertrophic pyloric stenosis.
Singh Utpal Kant, Kumar Ranjeet, Prasad Rajniti · Indian Pediatr · 2005
PMID: 15923695Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Atropine sulfate (substance)
SNOMED CT
74237004
UMLS CUI
C0596005

Clinical Data

This intervention maps to 7 entities in the Ltrl knowledge graph.

7
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
12
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.